Unfortunately, an error has occurred. Here you will find a list of possible results.
error
FIT tests for colorectal cancer screening
Bowel cancer is one of the most common types of cancer worldwide. In Germany, about 60,000 people are newly diagnosed every year, and about 460,000 people live with a colorectal cancer diagnosis. This type of cancer is easily treatable if diagnosed at an early stage. Regular colorectal cancer screening as prevention enables early detection of precancerous tumours. These preventive measures can counteract a diagnosis in the final stage with a poor prognosis.
Colorectal Cancer- how to prevent it
A guide to the importance of understanding and preventing bowel cancer through lifestyle changes and scientific strategies. It provides practical advice on diet, exercise and regular screening to significantly reduce the risk of developing this serious disease.
PreventID® Cardiac Troponin I
PreventID® Cardiac Troponin I is a simply designed test that uses a combination of particle-bound anti-cTnI antibodies in combination with a detection reagent to detect cTnI in whole blood, serum or plasma. The detection limit is equal to or higher than 0.5 ng/ml.
Darmkrebs – Immer noch ein Tabuthema
The fear of being diagnosed with bowel cancer and the feeling of powerlessness mean that far too little preventive care is still being taken. This is despite the fact that around 1.9 million people are diagnosed with colorectal cancer every year, more than 60,000 of them in Germany. With more than 24,000 deaths in Germany alone, colorectal carcinoma, i.e. cancer of the large intestine or rectum, is also the third most frequent cancer-related cause of death. For this reason, everyone should concern themselves with this topic - because bowel cancer screening can save lives!
But what is bowel cancer and how does the disease develop? What are the symptoms and signs? Do some people get bowel cancer more often than others? What can be done to prevent bowel cancer or increase the chances of curing it?
PreventID® Syphilis
PreventID® Syphilis uses a dual antigen combination of syphilis antigen-coated particles and syphilis antigen immobilized on the membrane to qualitatively and selectively detect TP antibodies (IgG and IgM) in whole blood, serum or plasma.
The test result can be read 5 minutes after application of the sample.